<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1.0"><title>Break a phase I/II outcome string into a list of cohort parts. — phase1_2_outcomes_to_cohorts • escalation</title><!-- favicons --><link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png"><link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png"><link rel="apple-touch-icon" type="image/png" sizes="180x180" href="../apple-touch-icon.png"><link rel="apple-touch-icon" type="image/png" sizes="120x120" href="../apple-touch-icon-120x120.png"><link rel="apple-touch-icon" type="image/png" sizes="76x76" href="../apple-touch-icon-76x76.png"><link rel="apple-touch-icon" type="image/png" sizes="60x60" href="../apple-touch-icon-60x60.png"><!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.7.1/jquery.min.js" integrity="sha512-v2CJ7UaYy4JwqLDIrZUI/4hqeoQieOmAZNXBeQyjo21dadnwR+8ZaIJVT8EE2iyI61OV8e6M8PP2/4hpQINQ/g==" crossorigin="anonymous" referrerpolicy="no-referrer"></script><!-- Bootstrap --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/css/bootstrap.min.css" integrity="sha256-bZLfwXAP04zRMK2BjiO8iu9pf4FbLqX6zitd+tIvLhE=" crossorigin="anonymous"><script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script><!-- bootstrap-toc --><link rel="stylesheet" href="../bootstrap-toc.css"><script src="../bootstrap-toc.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet"><script src="../pkgdown.js"></script><meta property="og:title" content="Break a phase I/II outcome string into a list of cohort parts. — phase1_2_outcomes_to_cohorts"><meta property="og:description" content="Break a phase I/II outcome string into a list of cohort parts.
Break a phase I/II outcome string into a list of cohort parts.
The outcome string describes the doses given, outcomes observed and the
timing of analyses that recommend a dose. The format of the string is
described in Brock _et al_. (2017).
The letters E, T, N &amp;amp; B are used to represents patients that experienced
(E)fficacy, (T)oxicity, (N)either and (B)oth. These letters are concatenated
after numerical dose-levels to convey the outcomes of cohorts of patients.
For instance, 2NET represents a cohort of three patients that were
treated at dose-level 2, one of whom experienced toxicity only, one that
experienced efficacy only, and one that had neither.
The results of cohorts are separated by spaces and it is assumed that a
dose-finding decision takes place at the end of a cohort. Thus,
2NET 1NN builds on our previous example, where the next cohort of two
were treated at dose-level 1 and neither of these patients experienced
either event See examples."><meta property="og:image" content="/logo.png"><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body data-spy="scroll" data-target="#toc">


    <div class="container template-reference-topic">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">escalation</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="">0.2.3</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav"><li>
  <a href="../reference/index.html">Reference</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    Articles

    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu"><li>
      <a href="../articles/A100-DoseSelectors.html">Using escalation</a>
    </li>
    <li>
      <a href="../articles/A205-CRM.html">CRM - Continual Reassessment Method</a>
    </li>
    <li>
      <a href="../articles/A207-NBG.html">NBG - Neuenschwander, Branson &amp; Gsponer</a>
    </li>
    <li>
      <a href="../articles/A210-TPI.html">TPI - Toxicity Probability Interval Design</a>
    </li>
    <li>
      <a href="../articles/A220-mTPI.html">mTPI - Modified Toxicity Probability Interval Design</a>
    </li>
    <li>
      <a href="../articles/A230-BOIN.html">BOIN - Bayesian Optimal Interval Design</a>
    </li>
    <li>
      <a href="../articles/A280-TITE.html">TITE-CRM and TITE-NBG - Time-to-Event Designs</a>
    </li>
    <li>
      <a href="../articles/A310-EfficacyToxicity.html">EffTox, Wages &amp; Tait, and BOIN12 - Efficacy &amp; Toxicity Designs</a>
    </li>
    <li>
      <a href="../articles/A360-Combinations.html">BOIN-COMB - Treatment Combination Designs</a>
    </li>
    <li>
      <a href="../articles/A600-DosePaths.html">Working with dose-paths</a>
    </li>
    <li>
      <a href="../articles/A700-Simulation.html">Simulating dose-escalation trials</a>
    </li>
    <li>
      <a href="../articles/A710-SimulationComparison.html">Comparing dose-escalation designs by simulation</a>
    </li>
  </ul></li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul><ul class="nav navbar-nav navbar-right"><li>
  <a href="https://github.com/brockk/escalation/" class="external-link">
    <span class="fab fa-github fa-lg"></span>

  </a>
</li>
      </ul></div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->



      </header><div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Break a phase I/II outcome string into a list of cohort parts.</h1>
    <small class="dont-index">Source: <a href="https://github.com/brockk/escalation/blob/HEAD/R/phase1_2_outcomes_to_cohorts.R" class="external-link"><code>R/phase1_2_outcomes_to_cohorts.R</code></a></small>
    <div class="hidden name"><code>phase1_2_outcomes_to_cohorts.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>Break a phase I/II outcome string into a list of cohort parts.</p>
<p>Break a phase I/II outcome string into a list of cohort parts.</p>
<p>The outcome string describes the doses given, outcomes observed and the
timing of analyses that recommend a dose. The format of the string is
described in Brock _et al_. (2017).</p>
<p>The letters E, T, N &amp; B are used to represents patients that experienced
(E)fficacy, (T)oxicity, (N)either and (B)oth. These letters are concatenated
after numerical dose-levels to convey the outcomes of cohorts of patients.
For instance, <code>2NET</code> represents a cohort of three patients that were
treated at dose-level 2, one of whom experienced toxicity only, one that
experienced efficacy only, and one that had neither.
The results of cohorts are separated by spaces and it is assumed that a
dose-finding decision takes place at the end of a cohort. Thus,
<code>2NET 1NN</code> builds on our previous example, where the next cohort of two
were treated at dose-level 1 and neither of these patients experienced
either event See examples.</p>
    </div>

    <div id="ref-usage">
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">phase1_2_outcomes_to_cohorts</span><span class="op">(</span><span class="va">outcomes</span><span class="op">)</span></span></code></pre></div>
    </div>

    <div id="arguments">
    <h2>Arguments</h2>


<dl><dt id="arg-outcomes">outcomes<a class="anchor" aria-label="anchor" href="#arg-outcomes"></a></dt>
<dd><p>character string representing the doses given, outcomes
observed, and timing of analyses. See Description.</p></dd>

</dl></div>
    <div id="value">
    <h2>Value</h2>
    <p>a list with a slot for each cohort. Each cohort slot is itself a
list, containing elements:
* <code>dose</code>, the integer dose delivered to the cohort;
* <code>outcomes</code>, a character string representing the <code>E</code>, <code>T</code>
<code>N</code> or <code>B</code> outcomes for the patients in this cohort.</p>
    </div>
    <div id="references">
    <h2>References</h2>
    <p>Brock, K., Billingham, L., Copland, M., Siddique, S., Sirovica, M., &amp; Yap, C.
(2017). Implementing the EffTox dose-finding design in the Matchpoint trial.
BMC Medical Research Methodology, 17(1), 112.
https://doi.org/10.1186/s12874-017-0381-x</p>
    </div>

    <div id="ref-examples">
    <h2>Examples</h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="va">x</span> <span class="op">=</span> <span class="fu">phase1_2_outcomes_to_cohorts</span><span class="op">(</span><span class="st">'1NEN 2ENT 3TB'</span><span class="op">)</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/base/length.html" class="external-link">length</a></span><span class="op">(</span><span class="va">x</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 3</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">1</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">dose</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 1</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">1</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">outcomes</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] "NEN"</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">2</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">dose</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 2</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">2</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">outcomes</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] "ENT"</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">3</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">dose</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 3</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">3</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">outcomes</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] "TB"</span>
<span class="r-in"><span></span></span>
</code></pre></div>
    </div>
  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top"><h2 data-toc-skip>Contents</h2>
    </nav></div>
</div>


      <footer><div class="copyright">
  <p></p><p>Developed by Kristian Brock, Daniel Slade, Michael Sweeting.</p>
</div>

<div class="pkgdown">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.1.</p>
</div>

      </footer></div>






  </body></html>

